Everdime Technologies, Inc.
RGST · OTC
3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.04 | -37.63 | -0.57 |
| FCF Yield | 0.18% | -0.11% | 0.05% | -0.11% |
| EV / EBITDA | 450.18 | -418.97 | 13,767.46 | -110.91 |
| Quality | ||||
| ROIC | 14.26% | 28.98% | -1.17% | 183.12% |
| Gross Margin | 55.92% | 0.00% | 100.00% | 0.00% |
| Cash Conversion Ratio | 1.13 | 0.58 | 7.83 | 0.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 698,435.03% | -42.09% | -28.31% | -42.92% |
| Free Cash Flow Growth | 0.00% | -319.07% | 138.88% | -0.60% |
| Safety | ||||
| Net Debt / EBITDA | 5.19 | -3.20 | 89.83 | -0.63 |
| Interest Coverage | 23.14 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 25.29 | 0.00 | 0.00 | -2,045.49 |